Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7.54 Billion | USD 20.70 Billion | 10.6% | 2024 |
The global prefilled syringes market size was worth around USD 7.54 Billion in 2024 and is predicted to grow to around USD 20.70 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 10.6% between 2025 and 2034.
The report analyzes the global prefilled syringes market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the prefilled syringes industry.
Prefilled Syringes are injectable medicine delivery containers that are devised for drug administration through the parental route. Furthermore, pharmaceutical firms are considering prefilled syringes as an effective tool for delivering a slew of injectable medicines including biosimilars and biologics. Reportedly, these products facilitate easy & quick drug delivery during emergencies.
The prefilled syringes help in reducing drug contamination risks through the insertion of a drug vial for drawing out a dose. Elimination of this medicine contamination risk with apre-sterilized syringe enhances safety along with removing the additional procedure of on-site vial cleaning as well asde-pyrogenation.
The massive necessity of prefilled syringes is owing to the rise in the occurrence of chronic ailments, technological breakthroughs, and surging acceptance of self-injecting parenteral equipment will drive market trends. Furthermore, favorable government laws overuse of prefilled syringes in the healthcare sector including clinics, hospitals, and ambulatory surgical units will open new vistas of growth for the prefilled syringes market. Apart from this, prefilled syringes help make injections easy, safe, and accurate for both subjects and physicians. This will create new growth avenues for the prefilled syringes industry.
Moreover, these medical devices have evolved as one of the rapidly emerging options for unit doses of medicine with the pharmaceutical sector seeking user-friendly drug delivery methods. This will drive market trends. In addition to this, prefilled syringes are compatible with auto-injection tools & secure equipment. Furthermore, these medical products find an array ofapplications in the therapeutic sector that include therapeutic proteins, vaccines, and blood stimulants. Elimination of dosing errors & user-friendliness are some of the beneficial features of filled syringes. These features differentiate it from conventional syringes and hence they are preferred over the latter.
The prefilled syringes market is expected to witness noticeable growth in the years to come on account of rapid growth in the biologics market, and the increasing preference for self-administration using prefilled syringes, pen injectors, and auto-injectors. Furthermore, prefilled syringes offer several benefits such as ease of administration, accurate dosing, and reduced risk of contamination. These advantages form the basic foundation for the success of prefilled syringes and are likely to continue to drive the market during the forecast period. However, the presence of alternative drug delivery means and the high cost associated with the production of prefilled syringes is expected to be a major restraining factor for this market. Nonetheless, technical advances in the sector are expected to open up new growth avenues within the forecast period.
The global prefilled syringes market is segmented based on material, type, application, and region.
Based on material, the prefilled syringes market can be segmented into glass-based prefilled syringes and plastic-based prefilled syringes. Glass-based prefilled syringes were the leading segment and it accounted for the largest share in terms of both volume and revenue. This growth is mainly attributed to glass as it offers favorable properties such as transparency, robustness, strength and chemical inertness. Plastic-based prefilled syringes are another key outlet and are expected to witness the fastest growth on account of the technological advancement of polymer technology-based plastics used to manufacture prefilled syringes.
By application, the prefilled syringes market is divided into diabetes, anaphylaxis, oncology, and rheumatoid arthritis.
On the basis of type, the prefilled syringes market can be segmented into with needles and without needles.
Report Attributes | Report Details |
---|---|
Report Name | Prefilled Syringes Market |
Market Size in 2024 | USD 7.54 Billion |
Market Forecast in 2034 | USD 20.70 Billion |
Growth Rate | CAGR of 10.6% |
Number of Pages | 185 |
Key Companies Covered | Bespak, Schott AG, Nipro Corporation, West Pharmaceutical Services Inc., Vetter Pharma International GmbH, Baxter International Inc., Becton, Dickinson & Company, Unilife Corporation, Stevanato Group, and Gerresheimer AG., and others., and others. |
Segments Covered | By Material, By Type, By Application, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Europe Prefilled Syringes Market To Retain DominanceOver 2022-2028
Regional market growth over the forecasting timespan can be credited to the rise in the use of biological medicines in the healthcare sector along with breakthroughs witnessed in prefilled syringe systems for fulfilling unmet requirements to treat chronic ailments in Europe. An increase in the use of biologics for treating chronic disorders along with the need for strong drug packaging in sophisticated container enclosures & drug delivery systems will spur the expansion of the prefilled syringe industry in the European continent.
The surge in demand for prefilled syringes to safely deliver bio-similar will expand the size of the prefilled syringes market in the region. Launching of new products by giant players coupled with large-scale acceptance of this medical equipment by healthcare service providers will promulgate the progression of the prefilled syringe market inthe European zone.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the prefilled syringes market on a global and regional basis
The global prefilled syringes market is dominated by players like:
The global prefilled syringes market is segmented as follows;
By Material
By Type
By Application
By Region
FrequentlyAsked Questions
Prefilled syringes (PFS) are single-dose, sterile medical devices pre-loaded with a specific medication or vaccine, ready for immediate administration. They eliminate the need for manual drug filling, reducing contamination risks and dosing errors.
The global prefilled syringes market is expected to grow due to increasing adoption in biologics and vaccines, preference for self-administration, and enhanced drug delivery efficiency.
According to a study, the global prefilled syringes market size was worth around USD 7.54 Billion in 2024 and is expected to reach USD 20.70 Billion by 2034.
The global prefilled syringes market is expected to grow at a CAGR of 10.6% during the forecast period.
North America is expected to dominate the prefilled syringes market over the forecast period.
Leading players in the global prefilled syringes market include Bespak, Schott AG, Nipro Corporation, West Pharmaceutical Services Inc., Vetter Pharma International GmbH, Baxter International Inc., Becton, Dickinson & Company, Unilife Corporation, Stevanato Group, and Gerresheimer AG., and others., among others.
The report explores crucial aspects of the prefilled syringes market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed